XML 77 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Share-based compensation (Tables)
 12 Months Ended
Jan. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Share-Based Compensation Expense and Associated Tax Benefits
Share-based compensation expense and the associated tax benefits recognized in the consolidated statements of operations are as follows:
(in millions)Fiscal 2021Fiscal 2020Fiscal 2019
Share-based compensation expense
$14.5 $16.9 $16.5 
Income tax benefit
$(3.6)$(4.2)$(4.1)
Summary of Unrecognized Compensation Cost Related to Outstanding Awards
As of January 30, 2021, unrecognized compensation cost related to unvested awards granted under share-based compensation plans is as follows:
(in millions)Unrecognized Compensation CostWeighted average period
Omnibus Plan
$26.6 2.2 years
Share Saving Plans
0.1 0.7 years
Total
$26.7 
Omnibus Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Significant Assumptions Utilized to Estimate Weighted-Average Fair Value of Awards Granted The significant assumptions utilized to estimate the weighted-average fair value of RSAs, Common Shares and RSU awards granted under the Omnibus Plans are as follows:
Omnibus Plan
Fiscal 2021Fiscal 2020Fiscal 2019
Share price
$11.10 $20.76 $41.36 
Expected term
2.9 years2.8 years2.8 years
Dividend yield
5.5 %7.5 %3.6 %
Fair value
$9.37 $18.14 $38.57 
The significant assumptions utilized to estimate the weighted-average fair value of stock options granted under the Omnibus Plans are as follows:
Fiscal 2020Fiscal 2019
Share price
$22.17 $40.09 
Exercise price
$25.18 $39.72 
Risk free interest rate
2.4 %2.9 %
Expected term
6.0 years6.5 years
Expected volatility
42.7 %37.6 %
Dividend yield
6.7 %3.7 %
Fair value
$4.27 $11.21 
Activity for Awards Granted Under the Plan
The Fiscal 2021 activity for Common Shares, RSAs, and time-based and performance-based RSU awards granted under the Omnibus Plans is as follows:
Omnibus Plans
(in millions, except per share amounts)
No. of
shares
Weighted
average
grant date
fair value		Weighted
average
remaining
contractual
life
Intrinsic
value(1)
Outstanding at February 1, 20202.8 $31.04 1.5 years$66.9 
Fiscal 2021 activity:
Granted
3.3 9.62 
Vested
(0.4)30.25 
Lapsed or forfeited
(0.9)34.20 
Outstanding at January 30, 20214.8 $15.24 1.8 years$192.3 
(1)    Intrinsic value for outstanding restricted stock and RSUs is based on the fair market value of Signet’s common stock on the last business day of the fiscal year.
The Fiscal 2021 activity for stock options granted under the Omnibus Plans is as follows:
Omnibus Plans
(in millions, except per share amounts)
No. of
shares
Weighted
average
exercise
price		Weighted
average
remaining
contractual
life
Intrinsic
value(1)
Outstanding at February 1, 20200.7 $39.13 8.3 years$— 
Fiscal 2021 activity:
Granted
— — 
Exercised
— — 
Lapsed or forfeited
(0.2)39.61 
Outstanding at January 30, 20210.5 $38.98 7.3 years$0.8 
(1)    Intrinsic value for outstanding awards is based on the fair market value of Signet’s common stock on the last business day of the fiscal year.
Summary of Additional Information about Awards Granted The following table summarizes additional information about awards granted under the Omnibus Plan:
(in millions)Fiscal 2021Fiscal 2020Fiscal 2019
Total intrinsic value of awards vested
$5.0 $3.5 $6.8 
Sharesave Plans  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Significant Assumptions Utilized to Estimate Weighted-Average Fair Value of Awards Granted
The significant assumptions utilized to estimate the weighted-average fair value of awards granted under the Sharesave Plans are as follows:
Fiscal 2019
Share price
$58.50 
Exercise price
$57.97 
Risk free interest rate
3.0 %
Expected term
3.7 years
Expected volatility
44.4 %
Dividend yield
2.6 %
Fair value
$18.07 
Activity for Awards Granted Under the Plan
The Fiscal 2021 activity for awards granted under the Sharesave Plans is as follows:
Sharesave Plans
(in millions, except per share amounts)
No. of
shares
Weighted
average
exercise
price		Weighted
average
remaining
contractual
life
Intrinsic
value(1)
Outstanding at February 1, 20200.1 $54.78 1.1 years$— 
Fiscal 2021 activity:
Granted
— — 
Exercised
— — 
Lapsed or forfeited
— — 
Outstanding at January 30, 20210.1 $51.30 0.8 years$— 
Exercisable at February 1, 2020— $— $— 
Exercisable at January 30, 2021— $— $— 
(1)    Intrinsic value for outstanding awards is based on the fair market value of Signet’s common stock on the last business day of the fiscal year.
Summary of Additional Information about Awards Granted
The following table summarizes additional information about awards granted under the Sharesave Plans:
(in millions, except per share amounts)Fiscal 2019
Weighted average grant date fair value per share of awards granted
$18.07 
Total intrinsic value of options exercised
$— 
Cash received from share options exercised
$—